D.A. Davidson & Co
AEMD icon

D.A. Davidson & Co’s Aethlon Medical AEMD Stock Holding History

D.A. Davidson & Co’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3
Closed -$22K – 1188
2021
Q1 		$22K Buy
+3
New +$28.9K ﹤0.01% 1147
2019
Q4 		– Hold
0
– -$2K – 1032
2019
Q3 		– Hold
0
– – – 1002
2019
Q2 		– Hold
0
– – – 991
2019
Q1 		– Hold
0
– – – 1133
2018
Q4 		– Hold
0
– – – 1087
2018
Q3 		– Hold
0
– – – 1160
2018
Q2 		– Hold
0
– – – 1116
2018
Q1 		– Hold
0
– – – 1099
2017
Q4 		– Hold
0
– – – 1107
2017
Q3 		– Hold
0
– -$3K – 1087
2017
Q2 		– Hold
0
– – – 2257
2017
Q1 		– Hold
0
– – – 2160

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Marshall Wace North America
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Cordasco Financial Network
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

D.A. Davidson & Co's AEMD Position: Q2 2021 in Review

D.A. Davidson & Co sold out of Aethlon Medical (AEMD) in Q2 2021, closing a stake of 3 shares — an estimated $22K sold.

D.A. Davidson & Co first reported a position in AEMD in Q1 2021 and held it in 1 quarter. The position peaked at $22K in Q1 2021. 12 funds tracked by Wall St. Rank hold AEMD as of Q2 2021.

  • D.A. Davidson & Co reported no remaining Aethlon Medical position as of Q2 2021 after selling out during the quarter.
  • D.A. Davidson & Co sold 3 Aethlon Medical shares in Q2 2021, an estimated $22K.
  • D.A. Davidson & Co first reported a position in Aethlon Medical in Q1 2021 and held it in 1 quarter.
  • D.A. Davidson & Co's Aethlon Medical position peaked at $22K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2021.

Based on D.A. Davidson & Co's 13F filing for Q2 2021, filed 10 Aug 2021.